Table 3 Suggestive associations identified by comparing increasing pain trajectory classes (classes 2–5; C2-5) to the no pain over time trajectory (class 1; C1). The results from the genome-wide multinomial logistic regression analysis (\(p<2\times{10}^{-6}\)) comparing subjects assigned to the four trajectories of increased pain over time (classes 2–5; C2-5) to subjects reporting no pain over time (class 1; C1), adjusting for age, sex, and the first three multi-dimensional scaling (MDS) components. Abbreviations: OR: odds ratio; MAF: minor allele frequency; CI: confidence interval; C1–C5: class 1 (no pain over time) to class 5 (severe pain over time). *Genes within +/-25 kilobases (kb).

From: Exploring the early drivers of pain in Parkinson’s disease

Chromosome

Base pair

position (hg38)

SNP

Risk allele

MAF

C2 vs. C1

OR

(95% CI)

C3 vs. C1

OR

(95% CI)

C4 vs. C1

OR

(95% CI)

C5 vs. C1

OR

(95% CI)

p-value

Nearest Gene*

11

36,234,620

rs61881484

T

0.078

1.00

(0.80, 1.25)

0.95

(0.73, 1.25)

1.73

(1.35, 2.22)

0.44

(0.19, 1.03)

\(1.96\times{10}^{-7}\)

LDLRAD3 (< 2.5 kb 5’)

3

134,281,183

rs9859176

T

0.399

1.05

(0.93, 1.19)

1.18

(1.02, 1.36)

1.49

(1.29, 1.73)

1.26

(0.93, 1.72)

\(3.28\times{10}^{-7}\)

 

3

134,011,416

rs7653639

T

0.184

1.17

(1.00, 1.36)

0.82

(0.678, 0.99)

0.77

(0.63, 0.94)

1.26

(0.86, 1.83)

\(1.49\times{10}^{-6}\)

SLCO2A1 (intronic)

3

134,217,925

rs9839609

T

0.389

1.06

(0.94, 1.20)

1.19

(1.03, 1.38)

1.46

(1.27, 1.70)

1.22

(0.90, 1.67)

\(1.73\times{10}^{-6}\)

RYK (intronic)

3

134,222,660

rs9865808

A

0.389

1.06

(0.94, 1.20)

1.19

(1.03, 1.38)

1.47

(1.27, 1.70)

1.22

(0.90, 1.67)

\(1.94\times{10}^{-6}\)

RYK (intronic)

11

36,232,669

rs11606598

C

0.074

1.00

(0.80, 1.26)

0.96

(0.73, 1.26)

1.68

(1.31, 2.16)

0.46

(0.20, 1.06)

\(1.99\times{10}^{-6}\)

LDLRAD3 (< 0.5 kb 5’)